Israel’s BrainStorm gets US patent for stem cell technology – Reuters UK

Israel s BrainStorm gets US patent for stem cell technologyReuters UKPending approval from the U.S. Food & Drug Administration, the company is preparing for its upcoming mid-stage Phase II trial in the United States with its NurOwn adult stem cell therapy. BrainStorm is developing NurOwn for the treatment of amyotrophic and more read more
http://blog.zandcell.com/israels-brainstorm-gets-us-patent-for-stem-cell-technology-reuters-uk/?utm_source=rss&utm_medium=rss&utm_campaign=israels-brainstorm-gets-us-patent-for-stem-cell-technology-reuters-uk